Farabi Pharmaceutical (XTEH:DFRB1) Tax Provision: IRR Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Farabi Pharmaceutical Tax Provision?

Farabi Pharmaceutical XTEH:DFRB1 Tax Provision is IRR Mil as of . 20.

Farabi Pharmaceutical's tax provision for the three months ended in . 20 was IRR0.00 Mil.

Farabi Pharmaceutical Tax Provision Historical Data

* Premium members only.

The historical data trend for Farabi Pharmaceutical's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Farabi Pharmaceutical Tax Provision Chart

Farabi Pharmaceutical Annual Data
Trend
Tax Provision

Farabi Pharmaceutical Quarterly Data
Tax Provision

Farabi Pharmaceutical Tax Provision Calculation

Tax to be paid.

Frequently Asked Questions Learn more about Tax Provision →
What does a Tax Provision of IRR Mil mean?
Farabi Pharmaceutical (XTEH:DFRB1) has a Tax Provision of IRR Mil as of . 20. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on Farabi Pharmaceutical and its competitors.
Is Farabi Pharmaceutical's Tax Provision too high?
Farabi Pharmaceutical's current Tax Provision is IRR Mil.
How does Farabi Pharmaceutical's Tax Provision compare to IMNPQ and INNV?
Farabi Pharmaceutical's Tax Provision of IRR Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Provision for a Drug Manufacturers company?
A good Tax Provision depends on the Drug Manufacturers industry context. However, Tax Provision should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Provision mean?
A high Tax Provision can signal that a stock is expensive relative to its fundamentals. Provision for taxes is the amount of tax the company owes based on pre-tax income. View historical data on Farabi Pharmaceutical and its competitors. Farabi Pharmaceutical's current Tax Provision is IRR Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farabi Pharmaceutical stock overvalued right now?
Farabi Pharmaceutical (XTEH:DFRB1) has a current Tax Provision of IRR Mil. The current Tax Provision is IRR Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Provision calculated?
Tax Provision is calculated from a company's financial statements. For Farabi Pharmaceutical (XTEH:DFRB1), the current Tax Provision is IRR Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Farabi Pharmaceutical Business Description

Address South Kheradmand, No. 45, First Floor, Tehran, IRN, 1584853114
Farabi Pharmaceutical is a pharmaceutical company based in Iran. It produces various oral antibiotic-related and non-antibiotic products and dietary supplements. The company develops anti-migraine, antivirals, cholesterol, diabetic, cardiovascular, gastrointestinal, neuroleptics, anti-prostatic and anti-inflammatory and pain release drugs. It offers products in the form of tablet, capsule and suspensions which include Amoxicillin, Cefixime, Azithromycin, Ciprofloxacin, Nitroglycerin, Repaglinide, Orlistat, Domperidone, among others.